Latest! Huaxi Hospital Will Introduce 66 Varieties

Pharmaceutical representatives note that the hospital has begun to open a pharmaceutical conferenceHuaxi Hospital, the introduction of 66 large varietiesMarch 11, Sichuan University Huaxi Hospital issued the "New Drug Introduction Announcement", a number of drugs originally not in the hospital procurement catalog, re-incorporated into the procurement scopeaccording to the announcement, the pharmaceutical management committee of Huaxi Hospital of Sichuan University, in strict accordance with the relevant regulations and procedures, carefully reviewed and discussed the pre-declared drug varieties, and finally decided to introduce the following 66 varieties:(source: Sichuan University Huaxi Hospital)from the rejection of Chinese medicine, to the introduction of Chinese medicinein fact, as early as January 3, Sichuan University Huaxi Hospital issued the "announcement on the receipt of new drug information declaration.", the new drug declaration principle is:(1) belongs to the "Sichuan Pharmaceutical Procurement Supervision" platform hanging network varieties(2) conforms to the National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drug Catalog policy, which will be implemented from January 1, 2020, and submits the drug standard code(3) in accordance with the National List of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drugs to be implemented from 1 January 2020, they must be "blood and hematopoietic organ drugs, cardiovascular systems, genitourinary drugs and sex hormones, systemic hormone preparations other than sex hormones and insulin, other, anti-tumor drugs and immunomodulators", and the national negotiating varieties(4) "All-body anti-infective drugs" shall be notified(Note: Huaxi Hospital on January 9 issued a "whole body anti-infective drugs" new drug information declaration notice)(5) the same declaration enterprise limited to 2 product regulations (national negotiating varieties are not restricted), if the over-declaration, all declarations are considered "invalid."the above principles must be met at the same timeour hospital already has "one product two rules" varieties, or the same quality or price level of drugs in the hospital, no longer accept the declarationThere is no restriction on the variety of national negotiationsfrom the above principles we can find that the introduction of Huaxi Hospital varieties, must be at the same time in line with the provincial platform hanging network, national health insurance catalog, the hospital has not yet reached the "one product two rules" requirementsdo not know whether everyone still has the impression, in 2015, Huaxi Hospital, a new drug introduction announcement on the basis of the above, there is a provision - tumor-assisted drugs, the national drug quasi-word number to "Z" the beginning of traditional Chinese medicine (a single ingredient content of more than 85% of the total extract of injections) temporarily not receivedincluding Xiangya II Hospital of Central South University in 2018 issued a "record procurement of drug information submission notice" also explicitly mentioned that Chinese medicine preparations, auxiliary drugs are not acceptedin that time, many hospitals in the record procurement link, for traditional Chinese medicine, auxiliary drug use is a refusal attitudeSome of the drugs that have not been used to win the winning bid, the new market related drugs, lost the last hope of entering the hospital through the record purchasein recent years, with the strong support of the state for Chinese medicine, the use of Chinese medicine in the clinical more and more standardized, in the hospital record procurement link, for traditional Chinese medicine attitude has changed a lotcan be found that in the past year, Huaxi Hospital in the declaration of new drugs, the content of the rejection of Chinese medicine almost completely disappeared, and on March 11 issued the "New Drug Introduction Notice", including jaundice secret soft capsules, sputum hot clear capsules and other traditional Chinese medicineIn addition, the hospital's "New Drug Introduction Announcement" issued on August 6, 2019 also includes the rehabilitation of new liquid, ginseng positive injection and other traditional Chinese medicinehowever, from the recent announcement of the introduction of new drugs published by Huaxi Hospital, mainly western drugsOne of the characteristics, many varieties are domestic generic drugs and original drugs introduced at the same timecan be foreseen, with the domestic generic drug consistency evaluation work, the quality of generic drugs continue to improve, as well as more and more high-quality generic drugs on the market, which will bring a huge impact on the original drug marketoriginal title: Latest! Big Three A Drug Association, Introduction of 66 Varieties